What is an Efficient and Affordable Trastuzumab Therapy in a Middle-Income Country? - Adjuvant Therapy with Trastuzumab in Management of Early HER2-Positive Breast Cancer in Iran
Abstract
Authors
A Ansaripour C Uyl-de Groot WK Redekop